SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-553077
Filing Date
2016-04-25
Accepted
2016-04-25 08:32:07
Documents
6
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d122664ddefa14a.htm DEFA14A 42625
2 GRAPHIC g122664naapg001.jpg GRAPHIC 2095
3 GRAPHIC g122664naapg002a.jpg GRAPHIC 2641
4 GRAPHIC g122664naapg002b.jpg GRAPHIC 2085
5 GRAPHIC g122664naapg003.jpg GRAPHIC 2103
6 GRAPHIC g122664naapg004.jpg GRAPHIC 2095
  Complete submission text file 0001193125-16-553077.txt   59764
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36332 | Film No.: 161587950
SIC: 2834 Pharmaceutical Preparations